Welcome to Dwaey, specifically on Dextran 70 0.2% + Hypromellose 0.2% Eye prep page.
This medicine contains important and useful components, as it consists of
Dextran 70 0.2% + Hypromellose 0.2% Eye prep is available in the market in concentration.
Dextran 70 0.2% + Hypromellose 0.2% Eye prep
Dextran 70 0.2% + Hypromellose 0.2% eye preparation is used primarily as a lubricant to relieve dryness, irritation, and discomfort in the eyes. Caution should be taken in patients with known hypersensitivity to any of the components, including dextran, hypromellose, or other ingredients. Though rare, allergic reactions, such as redness, itching, or swelling in and around the eye, may occur, requiring discontinuation of the product. If symptoms of an allergic reaction appear, patients should seek medical advice. The product should also be used with caution in individuals with eye conditions, such as corneal ulcers, ocular infections, or significant dry eye disease, as prolonged use could aggravate these conditions. When used during contact lens wear, the lenses should be removed prior to instillation, as some formulations may cause temporary blurring of vision or irritation. Patients with glaucoma should also be careful when using any eye product, as it may alter intraocular pressure measurements. During pregnancy or breastfeeding, the product should be used only if necessary, as safety data in these populations is limited. Regular monitoring of ocular health is recommended to prevent irritation or other complications from long-term use.
Dextran 70 0.2% + Hypromellose 0.2% is primarily indicated for the management of dry eye syndrome or conditions involving eye irritation. It is designed to provide lubrication and moisture to the ocular surface, particularly in patients experiencing discomfort due to environmental factors, such as wind, dry air, or prolonged screen time. The product is also useful during or after eye surgeries to maintain moisture on the corneal surface and promote healing. It can be used to relieve discomfort from minor irritations caused by contact lenses, eye trauma, or prolonged exposure to air conditioning or heating systems. The combination of dextran, a polysaccharide, and hypromellose, a cellulose derivative, ensures that the eye surface is hydrated for longer periods, alleviating discomfort and preventing further irritation. This product is typically not used for treating more severe eye conditions, such as infections, unless directed by a healthcare provider. Off-label uses may include aiding in post-surgical recovery and healing of the cornea after minor procedures or trauma.
Dextran 70 0.2% + Hypromellose 0.2% is contraindicated in patients who are hypersensitive to any of the components of the eye drops, including dextran, hypromellose, or any of the excipients. It should not be used in patients with ongoing eye infections, such as conjunctivitis or corneal ulcers, as the use of lubricating eye drops may worsen the infection by providing a medium for microbial growth. The product should also be avoided in individuals with significant eye disease or severe dry eye conditions that might require more intensive treatment, as prolonged use could mask underlying pathology or delay appropriate therapy. If there is a known history of allergy to cellulose derivatives or any other ingredient in the formulation, the product should not be used. For patients with glaucoma, caution is advised, as the drops could interfere with intraocular pressure measurements, potentially leading to inaccurate readings. It is important that patients consult their healthcare provider if they have any pre-existing ocular conditions or if they are experiencing symptoms that might require more specific treatment.
The side effects of Dextran 70 0.2% + Hypromellose 0.2% are generally mild and temporary. The most common adverse effects include mild ocular irritation, such as a burning or stinging sensation upon application, temporary blurred vision, or the feeling of having something in the eye. These symptoms typically subside within a few minutes after application and do not usually require discontinuation of the product. In rare cases, patients may experience allergic reactions, such as redness, swelling, or increased irritation. If these symptoms persist or worsen, it is important to discontinue use and consult a healthcare provider. Some individuals may also experience discomfort from prolonged use, particularly if the solution is not applied in accordance with the recommended dosage. If the symptoms of dryness or irritation are not alleviated, or if they worsen with continued use, patients should seek further medical advice. Serious side effects such as infection or worsening of existing ocular conditions are rare but may occur with improper use, such as contamination or using expired products.
Dextran 70 0.2% + Hypromellose 0.2% exerts its therapeutic effects by providing lubrication and moisture to the ocular surface, mimicking the natural tear film. The dextran component, a polysaccharide, helps maintain hydration by creating a protective layer on the corneal surface. This layer retains moisture and prevents the evaporation of tears, offering relief from dryness and irritation. Hypromellose, a cellulose derivative, acts as a stabilizing agent, enhancing the viscosity of the solution and prolonging its time on the eye’s surface. Together, these components form a moisture-retaining barrier that helps soothe and hydrate the eye, providing relief for symptoms caused by dry eye syndrome or environmental factors. The combination also helps in reducing friction between the eyelid and the ocular surface during blinking, improving comfort. The product is designed to be similar to natural tears in its structure and function, providing long-lasting hydration and promoting ocular health, especially after eye procedures or in patients experiencing mild to moderate dry eye symptoms.
Dextran 70 0.2% + Hypromellose 0.2% generally has minimal interactions with other medications when used as directed. However, when used in combination with other ocular products, it is recommended to space out the applications by at least 5 minutes to avoid interactions that could reduce the efficacy of either product. This is particularly important when using ocular medications that contain preservatives like benzalkonium chloride, as it can cause irritation or alter the effectiveness of the lubricant. When using contact lenses, the patient should remove them before instilling the drops and wait at least 15 minutes before reinsertion to ensure the solution has adequately settled in the eye. There are no known significant food, alcohol, or lifestyle interactions with this product. However, patients should be aware that this eye drop solution is designed to relieve discomfort from dryness and irritation and does not treat infections, so using it in conjunction with antibiotics or other ophthalmic medications should be done under the guidance of a healthcare provider. Always consult a healthcare professional before combining treatments for the eye.
For adults, the typical dosage of Dextran 70 0.2% + Hypromellose 0.2% is to instill 1 to 2 drops in the affected eye(s) up to 4 times daily or as needed for relief of dryness or irritation. The dosage can be adjusted based on the severity of symptoms, but it is not recommended to exceed 6 applications per day unless advised by a healthcare provider. In cases where the eye drops are used after surgery or in the treatment of minor eye trauma, the frequency of application may vary according to the doctor’s instructions. For optimal comfort, patients should ensure that they do not touch the tip of the dropper to the eye or any other surface to prevent contamination. If the drops cause temporary blurred vision or discomfort, patients should avoid driving or operating machinery until their vision clears.
For pediatric patients, the dosing of Dextran 70 0.2% + Hypromellose 0.2% is similar to that for adults. Typically, 1 drop is administered in the affected eye(s) up to 4 times per day or as necessary to relieve dryness or irritation. In younger children or infants, it is important to ensure that the product is being used under the supervision of a healthcare provider, especially in cases of severe dry eye symptoms or after eye surgeries. The frequency of application may be adjusted based on the severity of the condition and the child's specific needs. It is recommended to ensure that the child does not have an underlying ocular condition that requires a different treatment approach. Regular follow-up is essential to ensure the safety and efficacy of the product in pediatric patients.
There are no specific renal dose adjustments needed for Dextran 70 0.2% + Hypromellose 0.2% since the product is applied topically to the eye, and minimal systemic absorption occurs. Therefore, renal impairment does not significantly affect the use of this eye preparation. However, in patients with severe renal conditions, care should be taken with other systemic medications that may affect electrolyte balance, as this can indirectly impact ocular health or complicate dry eye treatment. It is important to monitor overall patient health and consult a healthcare provider for appropriate management if the patient has concurrent renal conditions or is on dialysis.
Not available in a medicine form yet